Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NSE - Delayed Quote INR

Gland Pharma Limited (GLAND.NS)

1,447.90
-17.60
(-1.20%)
At close: April 25 at 3:30:00 PM GMT+5:30
All numbers in thousands
Breakdown
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Assets
106,612,460
87,775,350
78,336,210
64,960,820
Total Liabilities Net Minority Interest
19,374,030
8,188,130
6,760,000
5,928,400
Total Equity Gross Minority Interest
87,238,430
79,587,220
71,576,210
59,032,420
Total Capitalization
88,303,830
79,619,830
71,614,420
59,071,760
Common Stock Equity
87,238,430
79,587,220
71,576,210
59,032,420
Capital Lease Obligations
523,840
6,320
8,100
9,260
Net Tangible Assets
83,693,650
79,470,610
71,450,860
59,032,420
Working Capital
42,467,890
61,716,750
52,700,540
46,111,140
Invested Capital
90,436,250
79,625,430
71,615,540
59,073,110
Tangible Book Value
83,693,650
79,470,610
71,450,860
59,032,420
Total Debt
3,721,660
44,530
47,430
49,950
Share Issued
164,710.52
164,700.82
164,302.72
163,592.92
Ordinary Shares Number
164,710.52
164,700.82
164,302.72
163,592.92
3/31/2021 - 11/20/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers